Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about Botulinum Toxin Therapy in Corticobasal Syndrome: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Botulinum toxin (BTX) injections represent a cornerstone of symptomatic management for corticobasal syndrome (CBS), particularly for addressing dystonia, spasticity, and related motor complications[@cbsdystonia]. Unlike dopaminergic therapies which demonstrate limited efficacy in CBS, botulinum toxi
No AI portrait yet
| Presynaptic inhibition | BTX cleaves SNAP-25, a protein essential for acetylcholine release at the neuromuscular junction |
| Temporary paralysis | This leads to chemical denervation of targeted muscles, reducing involuntary contractions |
| Duration | Effects typically last 3-4 months, requiring repeated injections for sustained benefit |
| Pain reduction | BTX reduces release of inflammatory mediators from nerve endings |
| Spasm relief | Decreased muscle spindle activity leads to reduced spasticity |
| Sensory gating | May interrupt aberrant sensory-motor feedback loops in damaged basal ganglia-cortical circuits |
| Cortical reorganization | Temporary paralysis allows for motor relearning |
| Neuroplasticity | May promote reorganization of motor maps in adjacent cortical regions |
| Long-term modulation | Repeated injections may lead to lasting changes in motor control patterns |
| Painful dystonic postures | Especially in upper extremities |
| Functional improvement | Enabling better hand use for activities of daily living |
| Gait improvement | Reducing scissoring or foot inversion during walking |
| KG Connections | 1 knowledge graph edges |
| Databases | OMIMOrphanetClinicalTrialsPubMed |
Knowledge base pages for this entity
flowchart TD
Botulinum_Toxin_Therapy_in_Cor["Botulinum Toxin Therapy in Corticobasal Syndr"] -->|"type of"| neurodegenerative_diseases["neurodegenerative_diseases"]
style Botulinum_Toxin_Therapy_in_Cor fill:#ef5350,stroke:#333,color:#000
style neurodegenerative_diseases fill:#4fc3f7,stroke:#333,color:#000| Target | Relation | Type | Str |
|---|---|---|---|
| neurodegenerative_diseases | type_of | domain | 0.30 |
| Source | Relation | Type | Str |
|---|---|---|---|
| No incoming edges | |||
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning Botulinum Toxin Therapy in Corticobasal Syndrome in their description or question text
No additional research found